Global Regulation of Antibiotic Sales Through Antimicrobial Stewardship Initiatives

Abstract

Antibiotics have played a crucial role in reducing the prevalence of infectious diseases, yet their irrational use has led to the growing threat of antimicrobial resistance (AMR), which significantly impacts global health, particularly in developing countries. Conventional infections are getting harder to treat with conventional antibiotics, which raises healthcare costs and puts a strain on finances, particularly for lower-income families. AMR is estimated to be the cause of 700,000 deaths per year. Self-medication is one form of misuse that hastens the emergence of resistant pathogens. The AWaRe classification, which divides antibiotics into Access, Watch, and Reserve categories to help inform treatment choices, was created by the World Health Organization (WHO) to encourage the prudent use of antibiotics. Additionally, poor-quality and fake medications lead to treatment failures, especially in environments with limited resources. Inadequate drug regulation makes this problem worse. Antibiotic Stewardship Programs (ASPs) are essential in the fight against antimicrobial resistance (AMR). Overuse of antibiotics in developed nations is a problem brought about by patient expectations, long-standing prescription practices, and insufficient surveillance systems. The efficacy of ASP in developing countries is hampered by inadequate resources, subpar diagnostics, self-medication, and lax regulatory frameworks. The problem is made more difficult by political unrest, healthcare fragmentation, and financial limitations. Better education, stricter laws, more efficient use of resources, and international cooperation in the fight against AMR are all necessary to address these issues.